Cargando…
GMP-Compliant Isolation and Large-Scale Expansion of Bone Marrow-Derived MSC
BACKGROUND: Mesenchymal stromal cells (MSC) have gained importance in tissue repair, tissue engineering and in immunosupressive therapy during the last years. Due to the limited availability of MSC in the bone marrow, ex vivo amplification prior to clinical application is requisite to obtain therape...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3419200/ https://www.ncbi.nlm.nih.gov/pubmed/22905242 http://dx.doi.org/10.1371/journal.pone.0043255 |
_version_ | 1782240701716627456 |
---|---|
author | Fekete, Natalie Rojewski, Markus T. Fürst, Daniel Kreja, Ludwika Ignatius, Anita Dausend, Julia Schrezenmeier, Hubert |
author_facet | Fekete, Natalie Rojewski, Markus T. Fürst, Daniel Kreja, Ludwika Ignatius, Anita Dausend, Julia Schrezenmeier, Hubert |
author_sort | Fekete, Natalie |
collection | PubMed |
description | BACKGROUND: Mesenchymal stromal cells (MSC) have gained importance in tissue repair, tissue engineering and in immunosupressive therapy during the last years. Due to the limited availability of MSC in the bone marrow, ex vivo amplification prior to clinical application is requisite to obtain therapeutic applicable cell doses. Translation of preclinical into clinical-grade large-scale MSC expansion necessitates precise definition and standardization of all procedural parameters including cell seeding density, culture medium and cultivation devices. While xenogeneic additives such as fetal calf serum are still widely used for cell culture, its use in the clinical context is associated with many risks, such as prion and viral transmission or adverse immunological reactions against xenogeneic components. METHODS AND FINDINGS: We established animal-free expansion protocols using platelet lysate as medium supplement and thereby could confirm its safety and feasibility for large-scale MSC isolation and expansion. Five different GMP-compliant standardized protocols designed for the safe, reliable, efficient and economical isolation and expansion of MSC was performed and MSC obtained were analyzed for differentiation capacity by qPCR and histochemistry. Expression of standard MSC markers as defined by the International Society for Cellular Therapy as well as expression of additional MSC markers and of various chemokine and cytokine receptors was analysed by flow cytometry. Changes of metabolic markers and cytokines in the medium were addressed using the LUMINEX platform. CONCLUSIONS: The five different systems for isolation and expansion of MSC described in this study are all suitable to produce at least 100 millions of MSC, which is commonly regarded as a single clinical dose. Final products are equal according to the minimal criteria for MSC defined by the ISCT. We showed that chemokine and integrin receptors analyzed had the same expression pattern, suggesting that MSC from either of the systems show equal characteristics of homing and adhesion. |
format | Online Article Text |
id | pubmed-3419200 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-34192002012-08-19 GMP-Compliant Isolation and Large-Scale Expansion of Bone Marrow-Derived MSC Fekete, Natalie Rojewski, Markus T. Fürst, Daniel Kreja, Ludwika Ignatius, Anita Dausend, Julia Schrezenmeier, Hubert PLoS One Research Article BACKGROUND: Mesenchymal stromal cells (MSC) have gained importance in tissue repair, tissue engineering and in immunosupressive therapy during the last years. Due to the limited availability of MSC in the bone marrow, ex vivo amplification prior to clinical application is requisite to obtain therapeutic applicable cell doses. Translation of preclinical into clinical-grade large-scale MSC expansion necessitates precise definition and standardization of all procedural parameters including cell seeding density, culture medium and cultivation devices. While xenogeneic additives such as fetal calf serum are still widely used for cell culture, its use in the clinical context is associated with many risks, such as prion and viral transmission or adverse immunological reactions against xenogeneic components. METHODS AND FINDINGS: We established animal-free expansion protocols using platelet lysate as medium supplement and thereby could confirm its safety and feasibility for large-scale MSC isolation and expansion. Five different GMP-compliant standardized protocols designed for the safe, reliable, efficient and economical isolation and expansion of MSC was performed and MSC obtained were analyzed for differentiation capacity by qPCR and histochemistry. Expression of standard MSC markers as defined by the International Society for Cellular Therapy as well as expression of additional MSC markers and of various chemokine and cytokine receptors was analysed by flow cytometry. Changes of metabolic markers and cytokines in the medium were addressed using the LUMINEX platform. CONCLUSIONS: The five different systems for isolation and expansion of MSC described in this study are all suitable to produce at least 100 millions of MSC, which is commonly regarded as a single clinical dose. Final products are equal according to the minimal criteria for MSC defined by the ISCT. We showed that chemokine and integrin receptors analyzed had the same expression pattern, suggesting that MSC from either of the systems show equal characteristics of homing and adhesion. Public Library of Science 2012-08-14 /pmc/articles/PMC3419200/ /pubmed/22905242 http://dx.doi.org/10.1371/journal.pone.0043255 Text en © 2012 Fekete et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Research Article Fekete, Natalie Rojewski, Markus T. Fürst, Daniel Kreja, Ludwika Ignatius, Anita Dausend, Julia Schrezenmeier, Hubert GMP-Compliant Isolation and Large-Scale Expansion of Bone Marrow-Derived MSC |
title | GMP-Compliant Isolation and Large-Scale Expansion of Bone Marrow-Derived MSC |
title_full | GMP-Compliant Isolation and Large-Scale Expansion of Bone Marrow-Derived MSC |
title_fullStr | GMP-Compliant Isolation and Large-Scale Expansion of Bone Marrow-Derived MSC |
title_full_unstemmed | GMP-Compliant Isolation and Large-Scale Expansion of Bone Marrow-Derived MSC |
title_short | GMP-Compliant Isolation and Large-Scale Expansion of Bone Marrow-Derived MSC |
title_sort | gmp-compliant isolation and large-scale expansion of bone marrow-derived msc |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3419200/ https://www.ncbi.nlm.nih.gov/pubmed/22905242 http://dx.doi.org/10.1371/journal.pone.0043255 |
work_keys_str_mv | AT feketenatalie gmpcompliantisolationandlargescaleexpansionofbonemarrowderivedmsc AT rojewskimarkust gmpcompliantisolationandlargescaleexpansionofbonemarrowderivedmsc AT furstdaniel gmpcompliantisolationandlargescaleexpansionofbonemarrowderivedmsc AT krejaludwika gmpcompliantisolationandlargescaleexpansionofbonemarrowderivedmsc AT ignatiusanita gmpcompliantisolationandlargescaleexpansionofbonemarrowderivedmsc AT dausendjulia gmpcompliantisolationandlargescaleexpansionofbonemarrowderivedmsc AT schrezenmeierhubert gmpcompliantisolationandlargescaleexpansionofbonemarrowderivedmsc |